WHO, 2017. Integrating Neglected Tropical Diseases into Global Health and Development: Fourth WHO Report on Neglected Tropical Diseases. Geneva, Switzerland: World Health Organization. Available at: https://www.who.int/neglected_diseases/resources/9789241565448/en/. Accessed February 12, 2019.
World Health Organization, 2001. Schistosomiasis and Soil-Transmitted Helminth Infections. Fifty-Fourth World Health Assembly. Ninth Plenary Meeting, May 2, 2001, Geneva, Switzerland. WHA54.19. Available at: http://apps.who.int/gb/archive/e/e_wha54.html. Accessed February 12, 2019.
WHO, 2018. Schistosomiasis and Soil-Transmitted Helminthiases: Number of People Treated in 2017. Weekly Epidemiological Record 50; 2018, 93 681–692. Available at: https://www.who.int/neglected_diseases/resources/who_wer9350/en/. Accessed February 13, 2019.
Cancrini G, Bartoloni A, Paradisi F, Nunez LE, 1989. Parasitological observations on three Bolivian localities including rural communities, cities and institutions. Ann Trop Med Parasitol 83: 591–594.
Bartoloni A, Guglielmetti P, Cancrini G, Gamboa H, Roselli M, Nicoletti A, Paradisi F, 1993. Comparative efficacy of a single 400 mg dose of albendazole or mebendazole in the treatment of nematode infections in children. Trop Geogr Med 45: 114–116.
Macchioni F, Segundo H, Gabrielli S, Totino V, Gonzales PR, Salazar E, Bozo R, Bartoloni A, Cancrini G, 2015. Dramatic decrease in prevalence of soil-transmitted helminths and new insights into intestinal protozoa in children living in the Chaco region, Bolivia. Am J Trop Med Hyg 92: 794–796.
Spinicci M 2018. Scaling down of a deworming programme among school-age children after a thirty-year successful intervention in the Bolivian Chaco. Trop Med Int Health 23: 616–621.
Spinicci M 2017. Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987–2013) in the absence of disease-specific control measures. Trop Med Int Health 22: 1457–1462.
D'Elios MM 1997. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leukoc Biol 61: 539–544.
Smits HH, Everts B, Hartgers FC, Yazdanbakhsh M, 2010. Chronic helminth infections protect against allergic diseases by active regulatory processes. Curr Allergy Asthma Rep 10: 3–12.
Alexandre-Silva GM, Brito-Souza PA, Oliveira ACS, Cerni FA, Zottich U, Pucca MB, 2018. The hygiene hypothesis at a glance: early exposures, immune mechanism and novel therapies. Acta Trop 188: 16–26.
Lienhardt C 2002. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 32: 1605–1613.
Macchioni F, Segundo H, Totino V, Gabrielli S, Rojas P, Roselli M, Paredes GA, Masana M, Bartoloni A, Cancrini G, 2016. Intestinal parasitic infections and associated epidemiological drivers in two rural communities of the Bolivian Chaco. J Infect Dev Ctries 10: 1012–1019.
Bartoloni A, Cancrini G, Bartalesi F, Marcolin D, Roselli M, Arce CC, Hall AJ, 1999. Mansonella ozzardi infection in Bolivia: prevalence and clinical associations in the Chaco region. Am J Trop Med Hyg 61: 830–833.
Nicoletti A 2002. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 58: 1256–1261.
Leonardi-Bee J, Pritchard D, Britton J, 2006. Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am J Respir Crit Care Med 174: 514–523.
Feary J, Britton J, Leonardi-Bee J, 2011. Atopy and current intestinal parasite infection: a systematic review and meta-analysis. Allergy 66: 569–578.
Wammes LJ, Mpairwe H, Elliott AM, Yazdanbakhsh M, 2014. Helminth therapy or elimination: epidemiological, immunological, and clinical considerations. Lancet Infect Dis 14: 1150–1162.